StonvexLoading…
StonvexStonvexStonvexCore line items from CIFR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.84M | $223.94M | $164.23M | $92.52M |
Operating Income | $-114.57M | $-421.56M | $-120.95M | $-83.33M |
Net Income | $-114.32M | $-822.24M | $-88.04M | $-84.76M |
EPS (Diluted) | $-0.28 | $-2.15 | $-0.23 | $-0.23 |
Total Assets | $6.39B | $4.29B | $2.84B | $1.02B |
Total Liabilities | $5.65B | $3.46B | $2.06B | $269.86M |
Cash & Equivalents | $715.20M | $628.26M | $1.21B | $62.70M |
Free Cash Flow OCF − CapEx | $-462.46M | $-695.86M | $-415.54M | $-159.32M |
Shares Outstanding | 405.27M | 404.96M | 393.60M | 386.76M |